BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30922234)

  • 1. Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease.
    Jortveit J; Halvorsen S; Kaldal A; Pripp AH; Govatsmark RES; Langørgen J
    BMC Cardiovasc Disord; 2019 Mar; 19(1):71. PubMed ID: 30922234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.
    Ergatoudes C; Thunström E; Rosengren A; Björck L; Bengtsson Boström K; Falk K; Fu M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):226. PubMed ID: 27855640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine.
    Gao ZY; Xu H; Shi DZ; Wen C; Liu BY
    J Ethnopharmacol; 2012 Jun; 141(2):578-83. PubMed ID: 21924336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline.
    Journath G; Hambraeus K; Hagström E; Pettersson B; Löthgren M
    BMC Cardiovasc Disord; 2017 Aug; 17(1):224. PubMed ID: 28814290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention.
    Garcia BH; Småbrekke L; Trovik T; Giverhaug T
    Eur J Clin Pharmacol; 2013 Mar; 69(3):703-9. PubMed ID: 22990329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines.
    Stark R; Kirchberger I; Hunger M; Heier M; Leidl R; von Scheidt W; Meisinger C; Holle R
    Clin Res Cardiol; 2014 Mar; 103(3):237-45. PubMed ID: 24287605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines).
    Smilowitz NR; Mahajan AM; Roe MT; Hellkamp AS; Chiswell K; Gulati M; Reynolds HR
    Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):e003443. PubMed ID: 29246884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
    Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing for Coronary Artery Disease in Older Patients With New-Onset Heart Failure: Findings From Get With The Guidelines-Heart Failure.
    O'Connor KD; Brophy T; Fonarow GC; Blankstein R; Swaminathan RV; Xu H; Matsouaka RA; Albert NM; Velazquez EJ; Yancy CW; Heidenreich PA; Hernandez AF; DeVore AD
    Circ Heart Fail; 2020 Apr; 13(4):e006963. PubMed ID: 32207996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to recommendations for secondary prevention medications after myocardial infarction in Estonia: comparison of real-world data from 2004 to 2005 and 2017 to 2018.
    Lõiveke P; Marandi T; Ainla T; Fischer K; Eha J
    BMC Cardiovasc Disord; 2021 Oct; 21(1):505. PubMed ID: 34670499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic CAD--do the guidelines (ESC, AHA) reflect daily practice?
    Tillmanns H; Erdogan A; Sedding D
    Herz; 2009 Feb; 34(1):39-54. PubMed ID: 19214408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk and predictors of cardiovascular death in stable coronary artery disease: the CORONOR study.
    Bauters C; Tricot O; Meurice T; Lamblin N;
    Coron Artery Dis; 2017 Dec; 28(8):636-641. PubMed ID: 28914638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study.
    Özcan C; Deleskog A; Schjerning Olsen AM; Nordahl Christensen H; Lock Hansen M; Hilmar Gislason G
    Eur Heart J Cardiovasc Pharmacother; 2018 Jan; 4(1):25-35. PubMed ID: 28444162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Outpatient Practice-Level Socioeconomic Disadvantage With Quality of Care and Outcomes Among Older Adults With Coronary Artery Disease: Implications for Value-Based Payment.
    Wadhera RK; Bhatt DL; Kind AJH; Song Y; Williams KA; Maddox TM; Yeh RW; Dong L; Doros G; Turchin A; Joynt Maddox KE
    Circ Cardiovasc Qual Outcomes; 2020 Apr; 13(4):e005977. PubMed ID: 32228065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries.
    Eggers KM; Hjort M; Baron T; Jernberg T; Nordenskjöld AM; Tornvall P; Lindahl B
    J Intern Med; 2019 Apr; 285(4):419-428. PubMed ID: 30474313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction.
    Somma KA; Bhatt DL; Fonarow GC; Cannon CP; Cox M; Laskey W; Peacock WF; Hernandez AF; Peterson ED; Schwamm L; Saxon LA
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):654-61. PubMed ID: 22949493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.